A look at the pharma industry’s concerted effort to develop vaccines against the SARS-CoV-2 virus and therapeutics to treat COVID-19.
Contract Pharma recently published an article authored by Keith O. Webber, Lachman Consultants. He says, “Although we are faced with significant challenges, hopefully the recently published guidance documents from the FDA in conjunction with the financial support from the Federal government and the efforts and ingenuity of the industrial sector will provide us with vaccines, therapeutics, and diagnostics that will allow the healthcare system to control the spread of the SARS-CoV-2 virus and minimize devastating health impacts of the associated COVID-19 disease.”
